Clinical Trials Directory

Trials / Completed

CompletedNCT00184912

The Effect of Caffeine on Ischemic Preconditioning

Caffeine Reduces Acute Ischemic Preconditioning

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (planned)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Ischaemic preconditioning (IP) describes the phenomenon that brief periods of ischaemia render the (myocardial) muscle more resistant to a subsequent more prolonged period of ischaemia and reperfusion. Animal studies have provided evidence that adenosine receptor stimulation is an important mediator of IP. As caffeine is an effective adenosine receptor antagonist already at concentrations reached after regular coffee consumption, we aimed to assess whether caffeine impairs IP in humans in vivo. We used a novel and well-validated model to study IP in humans: 99m-Tc-annexin A5 scintigraphy in forearm skeletal muscle. 24 healthy volunteers were randomly assigned to either caffeine (4 mg/kg/iv in 10 minutes) or saline before a protocol for IP.

Conditions

Interventions

TypeNameDescription
DRUGcaffeine
DRUGTechnetium-TC99m-labeled Annexin A5
PROCEDUREten minutes forearm ischemia
PROCEDUREischemic forearm exercise

Timeline

Start date
2003-09-01
Completion
2006-01-01
First posted
2005-09-16
Last updated
2006-11-29

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00184912. Inclusion in this directory is not an endorsement.